Cargando…
The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19)
The coronavirus disease of 2019 (COVID-19) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global pandemic with increasing incidence and mortality rates. Recent evidence based on the cytokine profiles of severe COVID-19 cases suggests an overstimulation of macrophages...
Autores principales: | Batra, Neelu, De Souza, Cristabelle, Batra, Jyoti, Raetz, Alan G., Yu, Ai-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503392/ https://www.ncbi.nlm.nih.gov/pubmed/32899231 http://dx.doi.org/10.3390/ijms21176412 |
Ejemplares similares
-
Exploring the therapeutic potential of Neem (Azadirachta Indica) for the treatment of prostate cancer: a literature review
por: Batra, Neelu, et al.
Publicado: (2022) -
SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1
por: Zhang, Shilei, et al.
Publicado: (2022) -
A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV
por: Singh, Ashutosh, et al.
Publicado: (2020) -
Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment
por: Kumar, Dharmender, et al.
Publicado: (2020) -
Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2
por: Zhou, Hong, et al.
Publicado: (2020)